![Sandesh Seth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandesh Seth
Vorstandsvorsitzender bei
ACTINIUM PHARMACEUTICALS, INC.
Vermögen: 206 619 $ am 30.09.2026
Profil
Mr. Sandesh Seth is a Chairman & Chief Executive Officer at Actinium Pharmaceuticals, Inc. and a Managing Partner at Jamess Capital Group LLC.
Mr. Seth was previously employed as a Lead Director by Camp Nine, Inc., a Lead Director by Relmada Therapeutics, Inc. /Old/, a Chairman by Relmada Therapeutics, Inc., and a Head-Healthcare Investment Banking by Laidlaw & Co. (UK) Ltd. He also served on the board at Cactus Ventures, Inc. and Actinium Pharmaceuticals, Inc. /Old/.
He received his undergraduate degree from the University of Mumbai and an MBA from New York University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.09.2026 | 184’481 ( 0.59% ) | 206 619 $ | 30.09.2026 |
Aktive Positionen von Sandesh Seth
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 09.06.2017 |
Jamess Capital Group LLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sandesh Seth
| Unternehmen | Position | Ende |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Vorsitzender | 06.06.2017 |
Laidlaw & Co. (UK) Ltd.
 Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Corporate Officer/Principal | 01.07.2015 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Direktor/Vorstandsmitglied | 18.04.2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Direktor/Vorstandsmitglied | 18.04.2013 |
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Ausbildung von Sandesh Seth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Finance |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for the treatment of acute and chronic pains | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Jamess Capital Group LLC | |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
